Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
Recruiting
N/A
Interventional Study
Open-angle Glaucoma (OAG)
Ocular Hypertension (OHT)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 172 (estimated)
- Sponsor
- Medical University of South Carolina · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study compares two FDA-approved laser treatments for glaucoma: Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT). Both procedures aim to lower eye pressure and prevent vision loss. DSLT is a newer, non-contact technique that may improve comfort and efficiency. Participants will be randomly assigned to receive either DSLT or SLT and followed for 12 months …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years
* Diagnosis of OAG (including exfoliative or pigmentary) or OHT
* Gonioscopically open angle (visible scleral spur 360°)
* Ability to consent and comply with follow-up
Exclusion Criteria:
* Angle-closure or secondary glaucomas
* IOP \>35 mmHg despite therapy
* …
Contacts
No contact information available.